Showing Results for
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedThe recent application of targeted immunotherapy has greatly improved the clinical outcomes of patients with lung adenocarcinoma (LUAD), but drug resistance continues to emerge, and to evaluate and to improve patient...
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedHypoxia and angiogenesis are the leading causes of tumor progression, and their strong correlation has been discovered in many cancers. However, their collective function's prognostic and biological roles were not...
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedOne of the most prevalent malignant primary brain tumors is primary glioma. Although glutathione peroxidase 8 (GPX8) is intimately associated with carcinogenesis, its function in primary gliomas has not yet been...
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedBackground and Aim. Chronic hepatitis B virus (HBV) infection is the leading global cause of hepatocellular carcinoma (HCC). Few studies have been conducted concerning the HBV infection-related genes and their function....
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedBackground. The objective of this study was to develop a nomogram that can predict lymph node metastasis (LNM) in patients with cervical adenocarcinoma (cervical AC). Methods. A total of 219 patients with cervical AC who...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it